Effect of levetiracetam on ocular perfusion measure with optical coherence tomography angiography
2022

Impact of Levetiracetam on Eye Blood Flow in Children

Sample size: 63 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kaderli Ahmet, Kayılıoğlu Hülya, Kaderli Sema Tamer, Karalezli Aylin

Primary Institution: Mugla Sitki Kocman University Research and Training Hospital

Hypothesis

Levetiracetam might have potential ocular side effects in pediatric patients with epilepsy.

Conclusion

Choroidal perfusion was reduced in children taking levetiracetam compared with that in the control group, whereas retinal perfusion was not affected.

Supporting Evidence

  • The choriocapillaris flow area was significantly lower in the Study Group than in the Control Group (p=0.006).
  • No significant difference in means of mean ocular perfusion pressure was found between the two groups (p=0.211).
  • Patients using multiple antiepileptic drugs were excluded from the study.

Takeaway

This study looked at how a medicine called levetiracetam affects blood flow in the eyes of children with epilepsy. It found that while the blood flow in one part of the eye was lower, other parts were not affected.

Methodology

The study included 33 pediatric patients with epilepsy and 30 healthy children, using optical coherence tomography angiography to evaluate blood flow.

Limitations

The study's cross-sectional design and lack of baseline OCTA values for the Study Group limit the interpretation of results.

Participant Demographics

33 pediatric patients with epilepsy and 30 age- and sex-matched healthy controls.

Statistical Information

P-Value

0.006

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.5935/0004-2749.2022-0269

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication